Hsinchu, Taiwan, 25th February, 2021 – Eden Biologics, Inc., a global frontrunner in biological drug development and manufacturing platform technologies, today announced completion of enrollment for their Phase 1 comparative... read more →
Hsinchu, Taiwan, February 19, 2021 – JHL Biotech, Inc., a global frontrunner in large-molecule biological drug development and manufacturing platform technologies, is excited to announce today that it has changed... read more →
Hsinchu and Taichung, Taiwan, September 11, 2020 - JHL Biotech, Inc. is extremely honored and proud to announce a signing of a Master Service Agreement (“MSA”) with Adimmune Corporation, a... read more →
JHL Biotech is extremely humbled and couldn’t be more proud to receive the 2020 Bioprocessing Excellence in Downstream Processing Award in the Greater China Region as part of IMAPAC’s Asia-Pacific... read more →
Melbourne, Australia and Hsinchu, Taiwan, 22 May 2020 – Q-Sera Pty Ltd is pleased to announce a collaboration with JHL Biotech, Inc. (Taiwan) to produce high yielding recombinant ecarin for... read more →
Hsinchu, Taiwan, May 18th, 2020 – JHL Biotech, Inc. today announced that the first group of subjects has been randomized and dosed last week in the company's Australian Phase I Clinical... read more →
HSINCHU, Taiwan, February 26, 2020 — With a globally-focused enthusiasm and aspiration to build sustainable and reputable CDMO facilities for the China Biologics Market, JHL Biotech has made a strategic... read more →
HSINCHU, Taiwan and WUHAN, China, August 16, 2019 -- JHL Biotech has reached a settlement agreement with Genentech to resolve Genentech’s civil claims related to the development of certain biologic... read more →
HSINCHU, Taiwan and WUHAN, China, June 13, 2018 /PRNewswire/ -- JHL Biotech has raised US$106 million in a convertible bond issuance, which closed May 15, 2018. Proceeds raised from the... read more →
HSINCHU, Taiwan and WUHAN, China, February 3, 2018 -- JHL Biotech (TPEx: 6540) announced that the Taipei Exchange (“TPEx”) granted approval on February 2 for the termination of trading of... read more →